Note |
Name of Cell |
Registry No. |
Animal |
Tissue |
Description |
|
0-9 |
Page Top |
|
|
|
|
104C1 |
JCRB9036 |
guinea pig |
fetal body |
fetal carcass, benzo(a)pyrene transformed, diploid |
|
16-8 |
JCRB0013 |
mouse |
antibody-producing hybridoma |
anti-human erythrocyte, IgM |
|
19-7 |
JCRB0014 |
mouse |
antibody-producing hybridoma |
anti-human erythrocyte, IgM |
|
293 |
JCRB9068 |
human |
kidney |
transformed embryonal kidney by adenovirus (type5) |
|
3LL |
JCRB1348 |
mouse |
lung |
Lewis lung cancer-derived cell line, (C57BL mouse) |
|
3'-mRLh-2 |
JCRB0431 |
rat |
liver |
hepatoma, (Donryu rat) |
|
3'-mRLN-30 |
JCRB0421 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
3'-mRLN-31 |
JCRB0422 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
3T3 L1 |
JCRB9014 |
mouse |
embryo |
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse) |
|
3T3-L1 |
IFO50416 |
mouse |
embryo |
fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse) |
|
3T3-Swiss albino |
IFO50417 |
mouse |
embryo |
fibroblast, contact inhibited, (Swiss albino mouse) |
|
3T3-Swiss albino |
JCRB9019 |
mouse |
embryo |
fibroblast, contact inhibited, (Swiss albino mouse) |
|
3T6-Swiss albino |
JCRB9059 |
mouse |
embryo |
fibroblast, collagen-secreting, (Swiss albino mouse) |
|
3Y1-B Clone 1-6 |
JCRB0734 |
rat |
embryo |
fibroblast, whole embryo, (Fischer 344 rat) |
|
4-2D |
JCRB0084 |
mouse |
antibody-producing hybridoma |
anti-primase complexed with DNA polymerase alpha |
|
4-8H |
JCRB0083 |
mouse |
antibody-producing hybridoma |
anti-DNA polymerase alpha, IgG1 |
|
4G12 hybridoma |
IFO50090 |
mouse x human |
antibody-producing hybridoma |
4G12 antibody, preferentially reacting with lung carcinoma-associated antigen |
|
5RP7 |
IFO50277 |
rat |
embryo |
fibroblast transformed by c-Ha-ras oncogene |
|
6-23 clone 6 |
IFO50270 |
rat |
thyroid |
medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat) |
|
77N1 |
IFO50280 |
rat |
kidney |
transformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat) |
|
7D4 |
JCRB9092 |
mouse x rat |
antibody-producing hybridoma |
anti-murine IL-2 receptors (rat antibody) |
|
8305C |
JCRB0824 |
human |
thyroid |
thyroid anaplastic carcinoma, undifferentiated |
|
8505C |
JCRB0826 |
human |
thyroid |
thyroid carcinoma, undifferentiated |
|
9-15c |
JCRB1181 |
mouse |
bone marrow |
mesenchymal cell line |
|
A |
Page Top |
|
|
|
|
A1 |
IFO50519 |
mouse |
neural |
derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells |
|
A-172 |
JCRB0228 |
human |
neural |
glioblastoma |
|
A2058 |
IFO50276 |
human |
melanoma |
malignant melanoma, metastasis to lymph node |
|
A2B5 clone 105 |
IFO50284 |
mouse |
antibody-producing hybridoma |
A2B5 antibody, recognizing a glycolipid expressed in neural tissue |
|
A3/KAW |
JCRB0101 |
human |
hemo-lymphocytic |
lymphoma, malignant |
|
A31-1-1 |
JCRB1356 |
mouse |
embryo |
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse) |
|
A31-714 C4 |
IFO50021 |
mouse |
embryo |
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse) |
|
A4/Fuk |
JCRB0097 |
human |
hemo-lymphocytic |
lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing |
|
A-431 |
IFO50411 |
human |
epidermoid carcinoma |
epidermoid carcinoma, high expression of EGF receptor |
|
A-431 |
JCRB0004 |
human |
epidermoid carcinoma |
epidermoid carcinoma, high expression of EGF-receptor |
|
A-431 |
JCRB9009 |
human |
epidermoid carcinoma |
epidermoid carcinoma, high expression of EGF-receptor |
|
A549 |
IFO50153 |
human |
lung (cancer) |
adenocarcinoma |
|
A549 |
JCRB0076 |
human |
lung (cancer) |
adenocarcinoma |
|
A9 |
JCRB0211 |
mouse |
skin |
skin fibroblast, 8-azaguanine-resistant, (C3H mouse) |
|
A9(0439)-1 |
JCRB0732 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome Xpter>Xq26::3p12>3pter |
|
A9(2621)-4 |
JCRB0730 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome 12pter>12q24::Xq22>Xqter |
|
A9(3552)-2 |
JCRB0731 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome 11pter>11q23::Xq26>Xqter |
|
A9(3884)-1 |
JCRB0729 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome 16pter>16q24::Xq26>Xqter |
|
A9(7151)-3 |
JCRB0728 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome 17pter>17q11::Xq11>Xqter |
|
A9(An4)-2 |
JCRB0727 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome # 1 |
|
A9(Bsr10) |
JCRB2210 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #10 |
|
A9(BsrX) |
JCRB2223 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome X |
*8) |
A9(Hygro13) |
JCRB2213 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #13 |
*8) |
A9(Hygro14) |
JCRB2214 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #14 |
*8) |
A9(Hygro21) |
JCRB2221 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #21 |
*8) |
A9(Hygro22) |
JCRB2222 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #22 |
|
A9(Neo1) |
JCRB2201 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 1 |
|
A9(neo11) |
JCRB2211 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #11 |
|
A9(Neo12) |
JCRB2212 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #12 |
|
A9(Neo15) |
JCRB2215 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #15 |
|
A9(Neo16) |
JCRB2216 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #16 |
*8) |
A9(Neo17) |
JCRB2217 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #17 |
|
A9(Neo18) |
JCRB2218 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #18 |
|
A9(Neo19) |
JCRB2219 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #19 |
|
A9(Neo2) |
JCRB2202 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 2 |
|
A9(Neo20) |
JCRB2220 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome #20 |
|
A9(Neo3) |
JCRB2203 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 3 |
|
A9(Neo4) |
JCRB2204 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 4 |
|
A9(Neo5) |
JCRB2205 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 5 |
|
A9(Neo6) |
JCRB2206 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 6 |
|
A9(Neo7) |
JCRB2207 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 7 |
|
A9(Neo8) |
JCRB2208 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 8 |
|
A9(NTI8)-2 |
JCRB0726 |
human chromosome-introduced |
human chromosomal hybrid |
contains human chromosome # 7 |
|
ABC-1 |
JCRB0815 |
human |
lung (cancer) |
adenocarcinoma |
|
Ac2F |
JCRB0408 |
rat |
liver |
normal liver, diploid, (Donryu rat) |
|
Ac2F(DT) |
JCRB0416 |
rat |
liver |
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat) |
|
Ac2F(ST) |
JCRB0417 |
rat |
liver |
Ac2F-derived, spontaneously transformed, (Donryu rat) |
|
Ad12-3Y1-Z19 |
JCRB0737 |
rat |
embryo |
3Y1 derivative, Ad12-transformed, (Fischer rat) |
|
AH601(JTC27) |
JCRB0132.1 |
rat |
liver |
transplantable ascites hepatoma, (Donryu rat) |
|
AH601.P3(JTC27) |
JCRB0132.2 |
rat |
liver |
transplantable ascites hepatoma, serum-free, (Donryu rat) |
|
AH601.P3(JTC27) |
JCRB0132.3 |
rat |
liver |
transplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat) |
|
AH66tc |
JCRB0411 |
rat |
liver |
ascites hepatoma, (Donryu rat) |
|
AH70Btc |
JCRB0412 |
rat |
liver |
ascites hepatoma, (Donryu rat) |
|
AH-7974.P3 |
JCRB0714.1 |
rat |
liver |
ascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat) |
|
AIG |
JCRB1105 |
hamster, Chinese |
lung |
anchorage-independent mutant of CHL |
|
Alexander cells |
IFO50069 |
human |
liver, gallbladder |
hepatoma, HBs antigen-positive |
|
AM-38 |
IFO50492 |
human |
neural |
glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive |
|
AP-16 |
IFO50424 |
mouse |
neural |
astrocyte-progenitor cell line, (C3H/He mouse) |
|
AR-EcoScreen |
JCRB1328 |
hamster, Chinese |
ovary |
androgen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required) |
|
ARLJ301-3 |
JCRB0248 |
rat |
liver |
liver epithelial cell, (F344/DuCrj rat) |
|
ASF-4-1 |
IFO50418 |
human |
skin |
skin, normal diploid fibroblast |
|
ASF-4-2 |
IFO50419 |
human |
skin |
skin, normal diploid fibroblast |
|
ASH-3 |
JCRB1073 |
human |
thyroid |
thyroid anaplastic carcinoma |
*2) |
AT(L)5KY |
JCRB0331 |
human |
hemo-lymphocytic |
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia |
*2) |
AT(L)6KY |
JCRB0332 |
human |
hemo-lymphocytic |
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia |
*2) |
AT(L)7KY |
JCRB0333 |
human |
hemo-lymphocytic |
EBV transformed B lymphoblastoid cell line, ataxia telangiectasia |
*2) |
AT1OS |
JCRB0308 |
human |
skin |
ataxia telangiectasia, fibroblast |
*2) |
AT2KY |
JCRB0316 |
human |
skin |
ataxia telangiectasia, fibroblast |
|
AtT-20 |
JCRB9098 |
mouse |
pituitary |
pituitary tumor, ACTH producing, (LAF1 mouse) |
|
AZ-521 |
JCRB0061 |
human |
stomach |
originally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80 |
|
B |
Page Top |
|
|
|
|
B-1 |
JCRB0243 |
mouse |
testis |
Leydig cell tumor, estrogen-dependent, (BALB/c mouse) |
|
B104 |
JCRB0117 |
human |
hemo-lymphocytic |
lymphoma, malignant B lymphoma |
*1) |
B104-R3 |
JCRB0117.1 |
human |
hemo-lymphocytic |
lymphoma, malignant B lymphoma, anti-IgM antibody resistant B104 |
|
B16 melanoma |
JCRB0202 |
mouse |
melanoma |
melanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse) |
|
B2-17 |
IFO50361 |
human |
neural |
astrocytoma, thymidine kinase-deficient mutant of U251 MG cells |
|
B8/3 |
JCRB0238 |
mouse |
hemo-lymphocytic |
erythroleukemia |
|
B82 |
JCRB0212 |
mouse |
skin |
skin fibroblast, bromodeoxyuridine-resistant |
|
B95-8 |
JCRB9123 |
cotten-top tamarin |
hemo-lymphocytic |
EBV transformed, release EBV infectious to primates |
|
BALB/3T3 A31-1-1 |
JCRB0601 |
mouse |
embryo |
fibroblast, contact inhibited, (BALB/c mouse) |
|
BALB/3T3 clone A31 |
JCRB9005 |
mouse |
embryo |
fibroblast, contact inhibited, (BALB/c mouse) |
|
Balb/3T3-A31-1-1 |
IFO50070 |
mouse |
embryo |
fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse) |
|
Balb/c 3T3 A31-1-13 |
IFO50299 |
mouse |
embryo |
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse) |
|
Balb/c 3T3 A31-I-1 |
IFO50298 |
mouse |
embryo |
fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse) |
|
BALB-MC |
JCRB0233.0 |
mouse |
mammary |
mammary cancer, (BALB/cHe mouse) |
|
BALB-MC.D3 |
JCRB0233.1 |
mouse |
mammary |
mammary cancer, (BALB/cHe mouse) |
|
BALB-MC.E12 |
JCRB0233.2 |
mouse |
mammary |
mammary cancer, (BALB/cHe mouse) |
|
BALL-1 |
JCRB0071 |
human |
hemo-lymphocytic |
leukemia, acute lymphoblastoid |
|
BCE C/D-1b |
JCRB9129 |
bovine |
cornea |
normal corneal epithelial cell, production of extracellular matrix proteins |
|
BCL1 Clone CW13.20 |
JCRB9117 |
mouse |
hemo-lymphocytic |
leukemia, B cell, (BALB/c mouse) |
*2) |
BCNS1KO |
JCRB0324 |
human |
skin |
basal cell nevus syndrome, fibroblasts |
|
Becker |
IFO50289 |
human |
neural |
astrocytoma, GFAP-negative |
|
BeWo |
JCRB9111 |
human |
placenta |
chorio carcinoma, trophoblastic cell line |
|
Bhas 42 |
JCRB0149 |
mouse |
embryo |
H-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse) |
|
BHK-21(C-13) |
JCRB9020 |
hamster, Syrian |
kidney |
kidney, subclone of BHK-21 |
|
BOKU |
IFO50323 |
human |
uterine cervix |
cervical squamous cell carcinoma |
|
BRL-3A |
JCRB0025 |
rat |
liver |
MSA (somatomedin-like) protein producing, (Buffalo rat) |
|
BRL-3A |
JCRB9114 |
rat |
liver |
MSA (somatomedin-like) protein producing, (Buffalo rat) |
*2) |
BS2CH |
JCRB0317 |
human |
skin |
Bloom's syndrome, fibroblast |
|
BS2CHTERT |
JCRB1061 |
human |
skin |
Bloom's syndrome, fibroblast, immortalized by hTERT |
|
BS-C-1 |
IFO50413 |
monkey, African green |
kidney |
suitable host for transfection experiments of SV40 vectors |
*1) |
BS-C-1 |
JCRB9011 |
monkey, African green |
kidney |
kidney |
|
BS-C-1 |
JCRB9126 |
monkey, African green |
kidney |
suitable host for transfection experiments of SV40 vectors |
|
BSL2KA |
JCRB1042 |
human |
hemo-lymphocytic |
EBV transformed B lymphoblastoid cell line from Bloom's syndrome patient |
|
BW5147.G.1.4.OUA-R.1 |
JCRB9002 |
mouse |
hemo-lymphocytic |
lymphoma, T cell lymphoma, (AKR/J mouse) |
|
C |
Page Top |
|
|
|
|
C32TG |
JCRB0227 |
human |
melanoma |
skin amelanotic melanoma, 6-thioguanine-resistant |
*1) |
C3H/10T1/2 clone 8 |
JCRB0602 |
mouse |
embryo |
fibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.) |
|
C3H/10T1/2 clone 8 |
JCRB9080 |
mouse |
embryo |
fibroblast, contact inhibited, (C3H mouse) |
|
C3H/10T1/2-clone 8 |
JCRB0003 |
mouse |
embryo |
fibroblast, contact inhibited, (C3H mouse) |
|
C3H/10T1/2-clone8 |
IFO50415 |
mouse |
embryo |
fibroblast, contact inhibited, (C3H mouse) |
|
C3H/MCA clone 15 |
IFO50042 |
mouse |
embryo |
3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse) |
|
C6 |
IFO50110 |
rat |
neural |
glial tumor, GFAP-positive |
|
C6 |
JCRB9096 |
rat |
neural |
glial tumor, GFAP-positive |
|
C6/36 |
IFO50010 |
mosquito |
hatched larvae |
useful for replication of flavivirus |
|
C6-SF2 |
IFO50425 |
rat |
neural |
C6 subline adapted to serum-free medium |
|
Ca Ski |
IFO50007 |
human |
uterine cervix |
cervical epidermoid cancer |
|
Ca9-22 |
JCRB0625 |
human |
oral |
squamous carcinoma, gingiva |
|
Caki-1 |
JCRB0801 |
human |
kidney |
renal clear cell carcinoma |
|
CaR-1 |
JCRB0207 |
human |
rectum |
adenocarcinoma |
*1) |
CCD 841 CoN |
IFO50482 |
human |
colon |
established from normal colonic tissue, epithelial-like, (distribution finished) |
|
CCD-14Br |
JCRB9101 |
human |
lung |
bronchus, diploid |
|
CCD-33Co |
IFO50483 |
human |
colon |
established from normal colon, fibroblast, (the lot in cellbank does not grow) |
|
CCK-81 |
JCRB0208 |
human |
colon |
adenocarcinoma |
|
CCRF S-180 II |
JCRB9089 |
mouse |
sarcoma |
S-180 sarcoma derivative |
|
CCRF-CEM |
IFO50412 |
human |
hemo-lymphocytic |
leukemia, acute T lymphoblastic |
|
CCRF-CEM |
JCRB0033 |
human |
hemo-lymphocytic |
leukemia, acute T lymphoblastic |
|
CCRF-CEM |
JCRB9023 |
human |
hemo-lymphocytic |
leukemia, acute T lymphoblastic |
|
CCRF-HSB2 |
JCRB0031 |
human |
hemo-lymphocytic |
leukemia, acute T lymphoblastic |
|
CCRF-SB |
IFO50026 |
human |
hemo-lymphocytic |
leukemia, acute B lymphoblastic |
|
CCRF-SB |
JCRB0032 |
human |
hemo-lymphocytic |
leukemia, acute B lymphoblastic |
|
Ch 1 Es |
JCRB9037 |
goat |
esophagus |
esophagus |
|
Chang Liver |
IFO50016 |
human |
HeLa-contaminant |
originally established from liver, HeLa-contaminated |
|
Chang Liver |
JCRB9066 |
human |
HeLa-contaminant |
originally established from liver, HeLa-contaminated |
|
CHL/IU |
JCRB0030 |
hamster, Chinese |
lung |
normal |
*8) |
CHO(His9) |
JCRB2209 |
human chromosome-introduced |
human monochromosomal hybrid panel |
contains human chromosome # 9 |
|
CHO(pMAM-HSluc) |
JCRB0136.2 |
hamster, Chinese |
ovary |
pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced |
|
CHO(pMAM-luc) |
JCRB0136.1 |
hamster, Chinese |
ovary |
pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone |
|
CHO/HGPRT |
JCRB0218 |
hamster, Chinese |
ovary |
HPRT-deficient CHO cell line |
|
CHO-K1 |
IFO50414 |
hamster, Chinese |
ovary |
subclone of CHO (Chainese hamster ovary) cells |
|
CHO-K1 |
JCRB9018 |
hamster, Chinese |
ovary |
subclone of CHO (Chainese hamster ovary) cells |
|
CKT-1 |
IFO50003 |
bovine |
kidney |
useful to assay bovine adenovirus 3 |
|
CKT-1 |
JCRB0008 |
bovine |
kidney |
useful to assay bovine adenovirus 3 |
|
CMK-11-5 |
IFO50430 |
human |
hemo-lymphocytic |
leukemia, acute megakaryoblastic |
|
CMK-86 |
IFO50428 |
human |
hemo-lymphocytic |
leukemia, acute megakaryoblastic |
|
CoCM-1 |
JCRB0257 |
human |
colon |
adenocarcinoma |
|
COLO201 |
JCRB0226 |
human |
colon |
adenocarcinoma |
|
COLO320 DM |
JCRB0225 |
human |
colon |
adenocarcinoma |
|
COS-1 |
JCRB9082 |
monkey, African green |
kidney |
SV40 transformed African green monkey kidney |
|
COS-7 |
IFO50068 |
monkey, African green |
kidney |
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing |
|
COS-7 |
JCRB9127 |
monkey, African green |
kidney |
transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing |
*1) |
CPA |
IFO50272 |
bovine |
vascular system |
pulmonary artery normal endothelial cell |
|
CPA |
JCRB9025 |
bovine |
vascular system |
pulmonary artery normal endothelial cell |
|
CPAE |
JCRB9022 |
bovine |
vascular system |
pulmonary artery normal endothelial cell |
|
CPT-K5 |
JCRB1067 |
human |
hemo-lymphocytic |
leukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402 |
|
CRFK |
JCRB9035 |
cat |
kidney |
kidney, BVD antigen negative |
|
cs-17-25 |
JCRB1102 |
hamster, Chinese |
lung |
cold-sensitive anchorage-independent growth mutant of CHL |
|
cs-19-36 |
JCRB1103 |
hamster, Chinese |
lung |
cold-sensitive anchorage-independent growth mutant of CHL |
|
cs-20-5 |
JCRB1104 |
hamster, Chinese |
lung |
cold-sensitive anchorage-independent growth mutant of CHL |
*2) |
CS2AW |
JCRB0310 |
human |
skin |
Cockayne's syndrome, fibroblast |
|
CS2AWTERT |
JCRB1059 |
human |
skin |
Cockayne's syndrome, fibroblast, immortalized by hTERT |
*2) |
CS2OS |
JCRB0309 |
human |
skin |
Cockayne's syndrome, fibroblast |
|
CS2OS(SVT) |
JCRB1056 |
human |
skin |
Cockayne's syndrome, fibroblast, immortalized by SV40 large T |
|
CV-1 |
JCRB9049 |
monkey, African green |
kidney |
kidney, highly susceptible to SV40 infection |
|
c-WRT-7-LR |
JCRB0168 |
rat |
hemo-lymphocytic |
RLV infected myelomonocytic leukemia. |
|
D |
Page Top |
|
|
|
*1) |
D422T |
JCRB9112 |
human |
sarcoma |
benign abdominal desmoid tumor |
|
Daudi |
JCRB9071 |
human |
hemo-lymphocytic |
lymphoma, Burkitt's |
|
DBC1.2 |
IFO50484 |
mouse |
olfactory epithelium |
dark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse) |
|
DD-762 |
JCRB1077 |
mouse |
mammary |
mammary tumor, producing MuMTV, (DD/Tbr mouse) |
|
De Gin |
JCRB9078 |
human |
skin |
osteoporosis, skin |
|
delta-47 |
JCRB1344 |
human |
hemo-lymphocytic |
myeloma, secreting IgD |
*1) |
Dempsey |
JCRB9088 |
human |
skin |
Klinefelter's syndrome, skin |
|
Detroit 510 |
JCRB9104 |
human |
skin |
galactosemia, skin |
|
Detroit 525 |
JCRB9102 |
human |
skin |
Turner's syndrome, skin |
*1) |
Detroit 529 |
JCRB9043 |
human |
skin |
Down's syndrome, skin |
|
Detroit 532 |
JCRB9044 |
human |
skin |
Down's syndrome, foreskin |
|
Detroit 539 |
JCRB9045 |
human |
skin |
Down's syndrome, skin |
|
DIG104.10H.1 |
JCRB1213.3 |
mouse |
antibody-producing hybridoma |
anti-digoxin antibody, subclass IgG1(k) |
|
DIG222.4D.5 |
JCRB1213.2 |
mouse |
antibody-producing hybridoma |
anti-digoxin antibody, subclass IgG2b(k) |
|
DL-40 |
JCRB1337 |
human |
hemo-lymphocytic |
lymphoma, non-Hodikin's, Ki-1-positive |
|
DLD-1 |
JCRB9094 |
human |
colon |
adenocarcinoma |
|
dRLa-74 Clone 2 |
JCRB0409 |
rat |
liver |
liver adenoma, (Donryu rat) |
|
dRLh-84 |
JCRB0410 |
rat |
liver |
hepatoma, (Donryu rat) |
|
dRLN-4 |
JCRB0418 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
dRLN-6 |
JCRB0420 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
dRLN-9 |
JCRB0419 |
rat |
liver |
liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat) |
|
DSPT200 |
JCRB0217 |
hamster, Syrian |
embryo |
fetus fibroblast transformed cell |
|
DT40 |
JCRB9130 |
chicken |
hemo-lymphocytic |
avian leukosis virus (ALV)-induced lymphomas |
|
E |
Page Top |
|
|
|
|
E1A-3Y1-1 |
JCRB0738 |
rat |
embryo |
3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat) |
*1) |
EB-3 |
IFO50028 |
human |
hemo-lymphocytic |
eliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line) |
|
EBC-1 |
JCRB0820 |
human |
lung (cancer) |
squamous cell carcinoma |
|
EBTr (NBL-4) |
JCRB9038 |
bovine |
lung |
embryonic trachea |
*5) |
ECV304 |
JCRB0744 |
human |
vascular system |
immortalized normal endothelium, contamination by T-24/EJ1 was suspected. |
|
EGV-4T |
JCRB0229 |
rat |
lung |
immortal cell line from MNNG-transformed tracheal epithelial cells |
|
Ehrlich ascites |
JCRB9090 |
mouse |
ascites |
Ehrlich-Lettre ascites carcinoma |
|
EHS |
IFO50268 |
mouse |
sarcoma |
chondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse) |
|
EJ-1 |
JCRB0710 |
human |
bladder |
bladder carcinoma, contamination by T24 cells has been suspected |
|
Ex-3LL |
JCRB1349 |
mouse |
lung |
Lewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse) |
|
F |
Page Top |
|
|
|
|
F119 |
JCRB1324 |
mouse |
antibody-producing hybridoma |
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b |
|
F2408 |
IFO50015 |
rat |
embryo |
fibroblast-like, (Fischer rat) |
|
F2408 EBNA2 cl-14 |
JCRB0143.5 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 EBNA2 cl-16 |
JCRB0143.2 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 EBNA2 cl-18 |
JCRB0143.3 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 EBNA2 cl-23 |
JCRB0143.6 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 EBNA2 cl-24 |
JCRB0143.4 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 EBNA2 cl-28 |
JCRB0143.7 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 EBNA2 cl-9 |
JCRB0143.1 |
rat |
embryo |
EBNA2-transfected, (Fischer rat) |
|
F2408 pZipNeo |
JCRB0143.0 |
rat |
embryo |
pZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat) |
|
F2408-B812 |
IFO50099 |
rat |
embryo |
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat) |
|
F2408-B993 |
IFO50100 |
rat |
embryo |
HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat) |
|
F2408-No.20 |
IFO50101 |
rat |
embryo |
thymidine kinase-deficient F2408 cell line, (Fischer rat) |
|
F2408-No.3 |
IFO50098 |
rat |
embryo |
HGPRT-deficient F2408 cell line, (Fischer rat) |
|
F2408-No.7 |
IFO50102 |
rat |
embryo |
HGPRT-deficient F2408 cell line, (Fischer rat) |
|
F25 |
JCRB1323 |
mouse |
antibody-producing hybridoma |
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a |
|
F56 |
JCRB1189 |
mouse |
antibody-producing hybridoma |
anti-CD307 (IRTA2/FcRH5/FCRL5), IgG1 |
|
F9 |
JCRB0721 |
mouse |
teratoma |
teratocarcinoma, differentiation-inducible, (129/Sv mouse) |
|
F9-41 |
JCRB0001 |
mouse |
teratoma |
teratocarcinoma, differentiation-inducible, (129/Sv mouse) |
*2) |
FA18JTO |
JCRB0315 |
human |
skin |
Fanconi's anemia, fibroblast |
*2) |
FA9JTO |
JCRB0314 |
human |
skin |
Fanconi's anemia, fibroblast |
|
FA9JTOTERT |
JCRB1060 |
human |
skin |
Fanconi's anemia, fibroblast, immortalized by hTERT |
|
FAA-HTC1 |
JCRB0249 |
rat |
liver |
hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat) |
|
FBHE |
IFO50154 |
bovine |
vascular system |
heart normal endothelial cell, FGF-dependent for survival |
|
FF101 |
JCRB1040 |
rat |
liver |
hepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat) |
|
FHs 74 Int |
JCRB9076 |
human |
intestine |
fetal small intestine, normal, (not intestinal epithelial cell) |
*1) |
FL* |
JCRB9016 |
human |
HeLa-contaminant |
originally established from amnion, HeLa-contaminated |
|
FLAM-76 |
JCRB1346 |
human |
hemo-lymphocytic |
myeloma, IL-6-dependent, growth is very slow |
|
Flow2000 |
IFO50089 |
human |
lung |
fetal lung, normal diploid fibroblast |
*1) |
Flow2000 |
JCRB0067 |
human |
lung |
fetal lung, normal diploid fibroblast (not available) |
|
Flow3000 |
JCRB0068 |
human |
neural |
normal fibroblast |
|
Flow7000 |
IFO50079 |
human |
skin |
skin, normal diploid fibroblast |
|
FLS3 |
IFO50377 |
mouse |
liver |
liver stromal cell line |
|
FLS5 |
IFO50378 |
mouse |
liver |
liver stromal cell line |
|
FM3A |
JCRB0701 |
mouse |
mammary |
mammary carcinoma, spontaneously obtained, (C3H/He mouse) |
|
FM3A APRT~ |
JCRB0703 |
mouse |
mammary |
mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse) |
|
FM3A HPRT~ |
JCRB0702 |
mouse |
mammary |
mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse) |
|
FM3A TK~ |
JCRB0704 |
mouse |
mammary |
mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse) |
*2) |
FPC15JTO |
JCRB0319 |
human |
skin |
familial polyposis coli, fibroblasts |
*2) |
FPC5JTO |
JCRB0318 |
human |
skin |
familial polyposis coli, fibroblasts |
|
FRSK |
JCRB0005 |
rat |
skin |
epidermal keratinocyte line from fetal skin |
|
FS-1 |
IFO50477 |
human |
bone marrow stroma |
bone marrow stromal cell from a myelogenous leukemia patient |
|
FSthy21 |
JCRB0719 |
mouse |
thymidylate defective |
complete defective strain of thymidylate synthase, (C3H mouse) |
|
FU97 |
JCRB1074 |
human |
stomach |
adenocarcinoma, poorly differentiated, AFP producing |
|
G |
Page Top |
|
|
|
|
G-292 clone A141B1 |
IFO50107 |
human |
sarcoma |
osteosarcoma |
|
G-361 |
IFO50009 |
human |
melanoma |
malignant melanoma, skin |
|
G-361 |
JCRB9074 |
human |
melanoma |
malignant melanoma, skin |
|
G-401 |
JCRB9065 |
human |
kidney |
Wilms' tumor (embryonal carcinosarcoma of kidney) |
|
G-402 |
JCRB9070 |
human |
kidney |
renal leiomyoblastoma |
|
GAK |
IFO50321 |
human |
melanoma |
malignant melanoma at external genitalia, metastasis to lymph node |
|
GAK |
JCRB0180 |
human |
melanoma |
malignant melanoma at external genitalia, metastasis to lymph node |
|
GB-1 |
IFO50489 |
human |
neural |
glioma, GFAP, vimentin and fibronectin-positive |
|
GCH-nu-YS |
JCRB1201 |
human |
uterus |
gestational uterine choriocarcinoma |
|
GH1 |
IFO50269 |
rat |
pituitary |
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) |
|
GH1 |
JCRB9046 |
rat |
pituitary |
pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat) |
|
GH3 |
IFO50105 |
rat |
pituitary |
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat) |
|
GH3 |
JCRB9047 |
rat |
pituitary |
pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat) |
|
GHBP116 |
JCRB1226 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone receptor antibody-producing, subclass IgG1(k) |
|
GOTO |
JCRB0612 |
human |
neural |
neuroblastoma, adrenal gland |
|
GOTO.P3 |
JCRB0612.1 |
human |
neural |
neuroblastoma, adrenal gland, serum-free |
*2) |
GP-1 |
JCRB1366 |
guinea pig |
hemo-lymphocytic |
Guinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.) |
|
GP8 |
JCRB1198 |
mouse |
skin |
human beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells) |
|
GRSL |
IFO50111 |
mouse |
hemo-lymphocytic |
thymic leukemia, (GR/A mouse) |
*2) |
GS33JTO |
JCRB0322 |
human |
skin |
Gardner's syndrome, fibroblasts, (M) |
*2) |
GS7OJTO |
JCRB0323 |
human |
skin |
Gardner's syndrome, fibroblasts |
|
H |
Page Top |
|
|
|
|
HARA |
JCRB1080.0 |
human |
lung (cancer) |
squamous carcinoma, PTHrP producing |
|
HARA-B |
JCRB1080.1 |
human |
lung (cancer) |
squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells |
|
HCA-1 |
JCRB1153 |
human |
uterine cervix |
endocervical adenocarcinoma endocervical adenocarcinoma cell line. |
*4) |
HCC-56 |
JCRB1037 |
human |
colon |
adenocarcinoma, moderately differentiated |
|
HCS-2 |
JCRB1203 |
human |
uterine cervix |
cervical squamous cell carcinoma |
|
HCSC-1 |
JCRB1205 |
human |
uterine cervix |
endocervical small cell carcinoma |
*2) |
HCT-2 |
JCRB1362 |
hamster, Syrian |
hemo-lymphocytic |
Hamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation). |
|
HD-70 |
JCRB1335 |
human |
hemo-lymphocytic |
lymphoma, from Hodgkin's |
|
HE-1 |
IFO50297 |
human |
embryo |
whole fetus, normal diploid fibroblast |
|
HEC-1 |
JCRB0042 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-108 |
JCRB1123 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-116 |
JCRB1124 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-151 |
JCRB1122 |
human |
uterus |
endometrial adenocarcinoma |
*5) |
HEC-155 |
JCRB1127 |
human |
uterus |
endometrial adenocarcinoma, (distribution was suspended) |
|
HEC-1-A |
JCRB1117 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-1-B |
JCRB1193 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-251 |
JCRB1141 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-265 |
JCRB1142 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-50B |
JCRB1145 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-59 |
JCRB1120 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-6 |
JCRB1118 |
human |
uterus |
endometrial adenocarcinoma |
|
HEC-88nu |
JCRB1121 |
human |
uterus |
endometrial adenocarcinoma |
|
HEL |
JCRB0062 |
human |
hemo-lymphocytic |
leukemia, erythroid |
|
HeLa |
JCRB9004 |
human |
uterine cervix |
epitheloid carcinoma |
|
HeLa 229 |
JCRB9086 |
human |
uterine cervix |
epitheloid carcinoma |
|
HeLa AG |
JCRB0213 |
human |
uterine cervix |
epitheloid carcinoma, 8-azaguanine-resistant |
|
HeLa S3 |
IFO50011 |
human |
uterine cervix |
cervical epithelioid carcinoma |
|
HeLa S3 |
JCRB9010 |
human |
uterine cervix |
cervical epitheloid carcinoma, adaptable to a suspension culture |
|
HeLa S3 (sc) |
JCRB0713 |
human |
uterine cervix |
HeLa derivative, can grow in suspension culture |
|
HeLa TG |
JCRB0214 |
human |
uterine cervix |
epitheloid carcinoma, 6-thioguanine-resistant |
|
HeLa TG Cap |
JCRB0215 |
human |
uterine cervix |
epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant |
|
HeLa.P3 |
JCRB0649 |
human |
uterine cervix |
serum free adapted HeLa cell line |
|
HeLa.P3 |
JCRB0649.1 |
human |
uterine cervix |
serum free adapted HeLa cell line, deposited by original developer |
|
HeLa.P3(S) |
JCRB0606 |
human |
uterine cervix |
HeLa cell derived, can grow in a serum-free medium |
|
HeLa9903 |
JCRB1318 |
human |
uterine cervix |
hERalpha-HeLa-9903, transfected with estrogen receptor-alpha – reporter gene construct. (MTA to developer is required) |
|
Hep G2 |
JCRB1054 |
human |
liver, gallbladder |
hepatoma |
|
HEPM |
JCRB9095 |
human |
oral |
embryonic palatal mesenchyme, limited life span |
|
HFb16d |
JCRB1008 |
human |
skin |
normal fibroblast transfected with HPV16 |
|
HFL1 |
IFO50074 |
human |
lung |
fetal lung, normal diploid fibroblast |
|
HGH1.1.3 |
JCRB1222.01 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH1.11.1 |
JCRB1222.08 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG2b(k) |
|
HGH1.15.3 |
JCRB1222.09 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH1.17.2 |
JCRB1222.03 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH1.31.3 |
JCRB1222.12 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH1.32.4 |
JCRB1222.13 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG2b(k) |
|
HGH1.35.2 |
JCRB1222.04 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG2a(k) |
|
HGH1.41.1 |
JCRB1222.10 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG2b(k) |
|
HGH1.46.1 |
JCRB1222.11 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG2b(k) |
|
HGH1.6.5 |
JCRB1222.02 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH1.8.1 |
JCRB1222.07 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG2b(k) |
|
HGH1.9.3 |
JCRB1222.06 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH2.15.4 |
JCRB1222.16 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(lambda) |
|
HGH2.4.2 |
JCRB1222.15 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HGH2.6.1 |
JCRB1222.05 |
mouse |
antibody-producing hybridoma |
anti-human growth hormone antibody, subclass IgG1(k) |
|
HH |
JCRB0099 |
bovine |
vascular system |
carotid artery normal endothelial cell |
|
HKA-1 |
JCRB1017 |
human |
skin |
giant keratoacanthoma |
|
HL60 |
JCRB0085 |
human |
hemo-lymphocytic |
leukemia, acute promyelotic, differentiation-inducible |
|
HL-60 |
IFO50022 |
human |
hemo-lymphocytic |
leukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced |
|
HL60(S) |
JCRB0163 |
human |
hemo-lymphocytic |
leukemia, acute promyelotic |
|
HL60RG |
JCRB0006 |
human |
hemo-lymphocytic |
leukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced |
|
HLCL-1 |
JCRB0041 |
human |
hemo-lymphocytic |
lymphocyte, peripheral |
|
HLE |
JCRB0404 |
human |
liver, gallbladder |
hepatoma, non-differentiated |
|
HLF |
JCRB0405 |
human |
liver, gallbladder |
hepatoma, non-differentiated |
|
HM-1 |
JCRB1208 |
hamster, Syrian |
hemo-lymphocytic |
macrophage line |
|
HMC-1-8 |
JCRB0166 |
human |
mammary |
breast cancer, target cell of the T-cell killer clone T(cHMC-1) |
|
HMY-1 |
JCRB1018 |
human |
melanoma |
malignant melanoma, sole, melanin production is poor |
|
HO-1-N-1 |
JCRB0831 |
human |
oral |
squamous carcinoma, buccal mucosa |
|
HO-1-u-1 |
JCRB0828 |
human |
oral |
squamous carcinoma, mouth floor |
|
HOS |
IFO50106 |
human |
sarcoma |
osteosarcoma |
|
HPSV178-4-3 |
JCRB1314 |
mouse |
antibody-producing hybridoma |
HPSV178 antibody, against GPI-anchorless splice variant of prion protein |
|
HR-3Y1-2 |
JCRB0743 |
rat |
embryo |
3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat) |
|
hs-103-3 |
JCRB1096 |
hamster, Chinese |
lung |
heat-sensitive anchorage-independent growth mutant of CHL |
|
hs-164-2 |
JCRB1097 |
hamster, Chinese |
lung |
heat-sensitive anchorage-independent growth mutant of CHL |
|
hs-171-1 |
JCRB1098 |
hamster, Chinese |
lung |
heat-sensitive anchorage-independent growth mutant of CHL |
|
hs-172-3 |
JCRB1099 |
hamster, Chinese |
lung |
heat-sensitive anchorage-independent growth mutant of CHL |
|
hs-211 |
JCRB1100 |
hamster, Chinese |
lung |
heat-sensitive anchorage-independent growth mutant of CHL |
|
HS-22 |
JCRB1215 |
mouse |
bone marrow |
mesenchymal stem cell line |
|
hs-222-3 |
JCRB1101 |
hamster, Chinese |
lung |
heat-sensitive anchorage-independent growth mutant of CHL |
|
Hs68 |
IFO50350 |
human |
skin |
skin, normal diploid fibroblast |
|
HSC-1 |
JCRB1015 |
human |
skin |
squamous carcinoma |
|
HSC-2 |
JCRB0622 |
human |
oral |
squamous carcinoma, mouth |
|
HSC-3 |
JCRB0623 |
human |
oral |
squamous carcinoma, tongue |
|
HSC-4 |
JCRB0624 |
human |
oral |
squamous carcinoma, tongue |
|
HSC-5 |
JCRB1016 |
human |
skin |
squamous carcinoma |
|
HSC-F |
JCRB1164 |
monkey, Cynomolgus |
hemo-lymphocytic |
HSV-immortalized T-cell line, susceptible to SIV |
|
HSGc-C5 |
JCRB1070 |
human |
HeLa-contaminant |
originally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation. |
|
HSP-239 |
JCRB1165 |
chimpanzee |
hemo-lymphocytic |
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri |
|
HSP-250 |
JCRB1177 |
chimpanzee |
hemo-lymphocytic |
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri |
|
HSR-5 |
JCRB1211 |
monkey, rhesus |
hemo-lymphocytic |
peripheral blood lymphocyte line immortalized with Herpesvirus saimiri |
|
HS-Sultan |
JCRB9062 |
human |
hemo-lymphocytic |
established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma) |
|
HT100 |
JCRB0221 |
hamster, Syrian |
lung |
lung, new born |
|
HT-1080 |
IFO50354 |
human |
sarcoma |
fibrosarcoma, acetabulum |
|
HT-1080 |
JCRB9113 |
human |
sarcoma |
fibrosarcoma, acetabulum |
|
HTC/C3 |
JCRB0164 |
human |
thyroid |
thyroid carcinoma |
|
HuCCT1 |
JCRB0425 |
human |
liver, gallbladder |
bile duct carcinoma |
*8) |
huH-1 |
JCRB0199 |
human |
liver, gallbladder |
hepatoma, HBs antigen-positive, HBc(-), HBe(-). |
|
HuH28 |
JCRB0426 |
human |
liver, gallbladder |
bile duct carcinoma |
|
HUH-6 Clone 5 |
JCRB0401 |
human |
liver, gallbladder |
hepatoblastoma, well differentiated |
|
HuH-7 |
JCRB0403 |
human |
liver, gallbladder |
hepatoma, differentiated |
*1) |
Human Mucosal cells |
JCRB9116 |
human |
colon |
colon |
|
HuO-3N1 |
JCRB0413 |
human |
sarcoma |
osteosarcoma, ilium |
|
HuO9 |
JCRB0427 |
human |
sarcoma |
osteosarcoma |
|
HuO9N2 |
JCRB0428 |
human |
sarcoma |
osteosarcoma |
|
HUV-EC-C |
IFO50271 |
human |
vascular system |
normal endothelial cell, umbilical cord |
|
I |
Page Top |
|
|
|
|
I-10 |
JCRB9097 |
mouse |
testis |
Leydig cell testicular tumor (BALB/cJ mouse) |
|
I51T |
JCRB1225 |
mouse |
skin |
deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells) |
|
IAR-20 |
JCRB0610 |
rat |
liver |
non-transformed live cell line, (BD-IV rat) |
|
IHH-4 |
JCRB1079 |
human |
thyroid |
thyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.) |
|
IM-9 |
IFO50025 |
human |
hemo-lymphocytic |
myeloma, multiple, B lymphoblastic |
|
IM-9 |
JCRB0024 |
human |
hemo-lymphocytic |
myeloma, multiple, B lymphoblastic |
|
IM95 |
JCRB1075.0 |
human |
stomach |
adenocarcinoma, moderately differentiated |
|
IM95m |
JCRB1075.1 |
human |
stomach |
adenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF |
|
IMR-32 |
IFO50283 |
human |
neural |
neuroblastoma |
|
IMR-32 |
JCRB9050 |
human |
neural |
neuroblastoma |
*4) |
IMR-90 |
JCRB0516 |
human |
lung |
fetal lung, normal diploid fibroblast |
|
IMR-90 |
JCRB9054 |
human |
lung |
fetal lung, normal diploid fibroblast |
|
IMR-90-40 |
JCRB0519 |
human |
lung |
fetal lung, normal diploid fibroblast, PDL=about 40 |
*3) |
IMR-90-50 |
JCRB0520 |
human |
lung |
fetal lung, normal diploid fibroblast, PDL=about 50 |
|
Indian Muntjac |
JCRB9100 |
Indian Muntjak |
skin |
used for chromosomal study |
|
IT-26R21 |
IFO50078 |
rat |
thymus |
T cell differentiation factor producing, (Wistar rat) |
|
IT-45R1 |
IFO50076 |
rat |
thymus |
T cell differentiation factor producing, (Wistar rat) |
|
IT-45R91 |
IFO50077 |
rat |
thymus |
thymic fibroblast, (Wistar rat) |
|
IT-79MTNC3 |
IFO50248 |
mouse |
thymus |
thymic nurse cell, (BALB/c mouse) |
|
ITO-II |
JCRB0613 |
human |
testis |
testicular tumor, (embryonal tumor) |
|
J |
Page Top |
|
|
|
|
J-111 |
IFO50005 |
human |
HeLa-contaminant |
originally established from acute monocytic leukemia, HeLa-contaminated |
|
J-111 |
JCRB0073 |
human |
HeLa-contaminant |
originally established from acute monocytic leukemia, HeLa-contaminated |
|
J774.1 |
JCRB0018 |
mouse |
hemo-lymphocytic |
monocyte-macrophage, IL-1-producing, (BALB/c mouse) |
|
J774A.1 |
JCRB9108 |
mouse |
hemo-lymphocytic |
monocyte-macrophage, (BALB/c mouse) |
*6) |
JHH-1 |
JCRB1062 |
human |
liver, gallbladder |
hepatoma |
*6) |
JHH-2 |
JCRB1028 |
human |
liver, gallbladder |
hepatoma |
*6) |
JHH-4 |
JCRB0435 |
human |
liver, gallbladder |
hepatoma |
*6) |
JHH-5 |
JCRB1029 |
human |
liver, gallbladder |
hepatoma |
*6) |
JHH-6 |
JCRB1030 |
human |
liver, gallbladder |
hepatoma |
*6) |
JHH-7 |
JCRB1031 |
human |
liver, gallbladder |
hepatoma, HBV-integration |
|
JKT-beta-del |
JCRB0147 |
human |
hemo-lymphocytic |
leukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex |
|
JTC-11 |
JCRB0424 |
mouse |
ascites |
Ehrlich ascites |
|
JTC-16 P3 |
JCRB0714 |
rat |
liver |
ascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat) |
|
JTC19 |
JCRB0608 |
rat |
lung |
lung, (JAR-1 rat) |
|
K |
Page Top |
|
|
|
|
K562 |
JCRB0019 |
human |
hemo-lymphocytic |
leukemia, chronic myelogenous, differentiation-inducible |
|
K562/ADM |
JCRB1002 |
human |
hemo-lymphocytic |
leukemia, chronic myelogenous, adriamycin resistant derivative of K562 |
|
KAI3 |
IFO50518 |
human |
hemo-lymphocytic |
EBV-infected NK-like cell line, IL-2 dependent |
|
KALS-1 |
IFO50434 |
human |
neural |
glioma, GFAP, vimentin and CD13-positive |
|
Kasumi-1 |
JCRB1003 |
human |
hemo-lymphocytic |
leukemia, acute myeloid |
|
Kasumi-3 |
JCRB1004 |
human |
hemo-lymphocytic |
leukemia, acute myeloperoxidase-negative |
|
Kasumi-6 |
JCRB1024 |
human |
hemo-lymphocytic |
leukemia, acute myeloid |
|
KATOIII |
JCRB0611 |
human |
stomach |
signet ring cell carcinoma |
|
KB |
JCRB9027 |
human |
HeLa-contaminant |
originally established from oral epidermoid carcinoma, HeLa-contaminated |
|
KCL-22 |
JCRB1317 |
human |
hemo-lymphocytic |
leukemia, chronic myelocytic, Ph1-positive |
|
KD |
JCRB9103 |
human |
oral |
fibroblast, lip |
|
KG-1 |
JCRB0065 |
human |
hemo-lymphocytic |
leukemia, acute myeloblastic |
|
KG-1 |
JCRB9051 |
human |
hemo-lymphocytic |
leukemia, acute myelogenous |
|
KG-1-C |
JCRB0236 |
human |
neural |
mixed glioma, GFAP-negative, S-100-positive |
|
KHM-10B |
JCRB0165 |
human |
hemo-lymphocytic |
lymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression |
|
KHM-1B |
JCRB0133 |
human |
hemo-lymphocytic |
myeloma, multiple, with hyperamylasemia. |
|
KHM-3S |
JCRB0138 |
human |
lung (cancer) |
small cell carcinoma, HTLV-1gene integration |
|
KHM-5M |
JCRB0148 |
human |
thyroid |
thyroid carcinoma, undifferentiated, IL-8 producing |
|
KHYG-1 |
JCRB0156 |
human |
hemo-lymphocytic |
leukemia, NK cell-like, IL-2 dependent |
|
Ki-JK |
JCRB1065 |
human |
hemo-lymphocytic |
lymphoma, anaplastic giant cell, Ki-1(CD30)-positive |
|
KINGS-1 |
IFO50435 |
human |
neural |
astrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive |
|
KMBC-2 |
JCRB1148 |
human |
bladder |
urinary bladder carcinoma |
|
KMH-2 |
JCRB1066 |
human |
thyroid |
thyroid anaplastic carcinoma |
|
KML-1 |
JCRB1347 |
human |
hemo-lymphocytic |
lymphoma, non-Hodgkins |
|
KMLS-1 |
JCRB0200 |
human |
sarcoma |
liposarcoma |
|
KMM-1 |
JCRB1180 |
human |
hemo-lymphocytic |
myeloma |
|
KMPC-3 |
JCRB1150 |
human |
kidney |
cell line derived from renal pelvis |
|
KMRC-1 |
JCRB1010 |
human |
kidney |
renal clear cell carcinoma |
|
KMRC-2 |
JCRB1011 |
human |
kidney |
renal clear cell carcinoma |
|
KMRC-20 |
JCRB1071 |
human |
kidney |
renal cancer |
|
KMRC-3 |
JCRB1012 |
human |
kidney |
renal clear cell carcinoma (growth is very slow) |
*4) |
KMRC-5 |
JCRB1007 |
human |
kidney |
renal clear cell carcinoma |
|
KMRM-M1 |
JCRB1014 |
human |
kidney |
renal carcinoma |
|
KMS-11 |
JCRB1179 |
human |
hemo-lymphocytic |
myeloma, multiple, IgG kappa-secreting, EBNA(-) |
|
KMS-12-BM |
JCRB0429 |
human |
hemo-lymphocytic |
myeloma, late stage of B-cell differentiation |
|
KMS-12-PE |
JCRB0430 |
human |
hemo-lymphocytic |
myeloma, late stage of B-cell differentiation |
|
KMS-20 |
JCRB1196 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-21BM |
JCRB1185 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-26 |
JCRB1187 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-27 |
JCRB1188 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-28BM |
JCRB1192 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-28PE |
JCRB1191 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-34 |
JCRB1195 |
human |
hemo-lymphocytic |
myeloma |
|
KMS-6 |
JCRB0432 |
human |
embryo |
fibroblast, normal diploid |
|
KMST-6 |
JCRB0433 |
human |
embryo |
fibroblast, immortalized by 60Co irradiation, derivative of KMS-6 |
*1) |
KMST-6/T |
JCRB0434 |
human |
embryo |
fibroblast, immortalized after extensive passages, derivative of KMS-6 |
|
KNS-42 |
IFO50356 |
human |
neural |
glioma, GFAP-positive, S-100 and NSE-negative |
|
KNS-60 |
IFO50357 |
human |
neural |
glioma, GFAP, S-100 and NSE-negative |
|
KNS-62 |
IFO50358 |
human |
lung (cancer) |
bronchial squamous carcinoma, metastasis to brain |
|
KNS-81 |
IFO50359 |
human |
neural |
glioma, GFAP and S-100-positive, NSE-negative |
|
KNS-81-FD |
IFO50444 |
human |
neural |
glioma, derivative of KNS-81 adapted to serum-free medium |
*1) |
KNS-89 |
IFO50360 |
human |
neural |
gliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.) |
*5) |
KO51 |
JCRB0122 |
human |
hemo-lymphocytic |
leukemia, acute myeloblastic, contamination of K562 has been suspected. |
|
KO52 |
JCRB0123 |
human |
hemo-lymphocytic |
leukemia, acute myeloblastic |
|
KON |
JCRB0194 |
human |
oral |
squamous carcinoma, mouth, ras P21 expression |
|
KOSC-2 cl3-43 |
JCRB0126.1 |
human |
oral |
squamous carcinoma, stage III, oral floor |
*5) |
KOSC-3 |
JCRB0127 |
human |
oral |
squamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected. |
*5) |
KP-1N |
JCRB0177.0 |
human |
pancreas |
pancreatic cancer, adenocarcinoma (distribution is suspended) |
*5) |
KP-1NL |
JCRB0177.1 |
human |
pancreas |
pancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended) |
|
KP-2 |
JCRB0181 |
human |
pancreas |
pancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma |
|
KP-3 |
JCRB0178.0 |
human |
pancreas |
pancreatic cancer, adenosquamous carcinoma |
|
KP-3L |
JCRB0178.1 |
human |
pancreas |
pancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice |
|
KP-4 |
JCRB0182 |
human |
pancreas |
pacnreatic ductal cell carcinoma, secreting PTHrP |
|
KP-N-RT-BM-1 |
IFO50432 |
human |
neural |
neuroblastoma, from bone marrow, neuronal and Schwannian differentiation |
|
KP-N-SI9s |
IFO50433 |
human |
neural |
neuroblastoma, from lymph node, smooth muscle marker-expressing |
|
KP-N-YN |
IFO50431 |
human |
neural |
neuroblastoma, from lymph node, smooth muscle marker-expressing |
|
KS-1 |
IFO50436 |
human |
neural |
glioblastoma |
|
KT-5 |
IFO50161 |
mouse |
neural |
astrocyte line, GFAP-positive, (C3H/He mouse) |
|
KU812 |
IFO50363 |
human |
hemo-lymphocytic |
leukemia, chronic myeloid |
|
KU812 |
JCRB0104 |
human |
hemo-lymphocytic |
leukemia, chronic myeloid |
|
KU812E |
JCRB0104.1 |
human |
hemo-lymphocytic |
leukemia, chronic myeloid |
|
KU812F |
JCRB0104.2 |
human |
hemo-lymphocytic |
leukemia, chronic myeloid |
|
KUM10 |
JCRB1176 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUM3 |
JCRB1134 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUM4 |
JCRB1135 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUM5 |
JCRB1178 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUM6 |
JCRB1202 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUM7 |
JCRB1204 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUM9 |
JCRB1139 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KURAMOCHI |
JCRB0098 |
human |
ovary |
undifferentiated carcinoma, ascites |
|
KUSA-A1 |
JCRB1119 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUSA-H1 |
JCRB1129 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KUSA-O |
JCRB1132 |
mouse |
bone marrow |
osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse) |
|
KY821 |
JCRB0105 |
human |
hemo-lymphocytic |
leukemia, acute myeloid |
|
KY821A3 |
JCRB0105.1 |
human |
hemo-lymphocytic |
leukemia, acute myeloid, subclone of KY821 |
|
KYM-1 |
JCRB0627 |
human |
sarcoma |
rhabdomyosarcoma, neck |
*6) |
KYSE110 |
JCRB1064 |
human |
esophagus |
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE140 |
JCRB1063 |
human |
esophagus |
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE150 |
JCRB1095 |
human |
esophagus |
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE170 |
JCRB1082 |
human |
esophagus |
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE180 |
JCRB1083 |
human |
esophagus |
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE220 |
JCRB1086 |
human |
esophagus |
squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE270 |
JCRB1087 |
human |
esophagus |
squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE30 |
JCRB0188 |
human |
esophagus |
squamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE50 |
JCRB0189 |
human |
esophagus |
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
*6) |
KYSE70 |
JCRB0190 |
human |
esophagus |
squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order) |
|
L |
Page Top |
|
|
|
|
L alpha |
JCRB0125 |
mouse |
skin |
L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective |
|
L cl 1D |
JCRB0722 |
mouse |
skin |
fibroblast, thymidine kinase-deficient, (C3H mouse) |
|
L.P3 |
JCRB0648 |
mouse |
skin |
serum-free adapted L929 cell line |
|
L.P3(S) |
JCRB0605 |
mouse |
skin |
L cell derived, can grow in a serum-free medium, (C3H mouse) |
|
L1210 |
JCRB9026 |
mouse |
hemo-lymphocytic |
leukemia, lymphocytic, (DBA/2 mouse) |
|
L-2 |
JCRB9053 |
rat |
lung |
adult lung |
|
L2C |
IFO50210 |
guinea pig |
hemo-lymphocytic |
leukemic cell, maintainable only by transplantation |
|
L5178Y |
JCRB0709 |
mouse |
hemo-lymphocytic |
lymphoma, methylcholanthrene induced, (DBA/2 mouse) |
|
L5178Y TK+/-3.7.2c |
JCRB0709.1 |
mouse |
hemo-lymphocytic |
L5178Y derivative, thymidine kinase +/- heterozygotic line |
|
L5178Y ts2 |
JCRB0723 |
mouse |
hemo-lymphocytic |
L5178Y derivative, abnormal cell division at non-permissive temperature |
|
L5178Y ts39 |
JCRB0724 |
mouse |
hemo-lymphocytic |
L5178Y derivative, micronucleation at non-permissive temperature |
|
L6 |
IFO50364 |
rat |
muscular system |
skeletal muscle myoblast |
|
L6 |
JCRB9081 |
rat |
muscular system |
skeletal muscle myoblast |
|
L6TG |
JCRB0209 |
rat |
muscular system |
skeletal muscle myoblast, 6-thioguanine-resistant |
|
L6TG Cap |
JCRB0210 |
rat |
muscular system |
skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant |